Bausch & Lomb (NYSE: BLCO) director buys shares, gets RSUs

Rhea-AI Filing Summary

Bausch & Lomb Corp director Andrew C. Von Eschenbach reported two transactions in common shares. He made an open-market purchase of 4,364 shares at $18.305 per share, increasing his direct holdings to 66,450 shares. In connection with this purchase, he also received a grant of 4,364 matching restricted share units under the company’s matching share program, which will vest in three equal installments on each of the first, second, and third anniversaries of the grant date, subject to his continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VON ESCHENBACH ANDREW C.

(Last) (First) (Middle)

C/O BAUSCH + LOMB CORPORATION

520 APPLEWOOD CRESCENT

(Street)

VAUGHAN A6 L4K 4B4

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	02/27/2026		P		4,364	A	$18.305	66,450	D
Common Shares, No Par Value	02/27/2026		A		4,364(1)	A	$0	70,814	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).

	/s/ Debra E. Levin, attorney-in-fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did BLCO director Andrew C. Von Eschenbach report?

Andrew C. Von Eschenbach reported buying 4,364 Bausch & Lomb common shares and receiving 4,364 matching restricted share units. The transactions reflect an open-market purchase plus a related equity award under the company’s matching share program.

At what price did the BLCO director purchase common shares?

The director bought 4,364 Bausch & Lomb common shares at an average price of $18.305 per share. This open-market purchase increased his directly held position, as reported in the Form 4 insider trading disclosure.

How many Bausch & Lomb shares does the director own after these transactions?

After the open-market purchase, Andrew C. Von Eschenbach directly owned 66,450 Bausch & Lomb common shares. A separate grant of 4,364 matching restricted share units was also reported, which are scheduled to vest over three years.

What are the terms of the matching restricted share units granted to the BLCO director?

The director received 4,364 matching restricted share units tied to his open-market purchase. One-third of these units will vest on each of the first, second, and third anniversaries of the grant date, subject to his continued service with the company.

Why did the BLCO director receive restricted share units in addition to purchasing shares?

The restricted share units were granted under Bausch & Lomb’s matching share program, which issues matching RSUs when eligible participants buy shares. In this case, the grant matched the 4,364 shares purchased in the open market.